arct-154
Vaccineexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Aug 15, 2021 (NCT05012943)
Timeline
Indications
Mechanism of action
- SARS-CoV-2Immunity, active
SARS-CoV-2 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05037097 | Phase 1/Phase 2 (Phase 2) | Aug 30, 2021 | Arcturus Therapeutics |
| NCT05012943 | Phase 2/Phase 3 (Phase 3) | Aug 15, 2021 | Arcturus Therapeutics |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Arcturus Therapeutics | For profit | 2 | 2 | 2 | 2021 |
1 organizations
Page 1 / 1